tradmap

SMG Financials Scotts Miracle-Gro Co

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has declined 3.7% per year over the past 5 years.
  • Net income has grown slower than revenue (-17.8% vs -3.7% per year).
  • Operating margin has contracted, at 10.5% in the latest year.
  • Free cash flow has declined 11.2% per year over the past 5 years.

Financial health

  • Total debt ($2.1B) exceeds cash ($33M); net debt is $2.1B.
  • Total debt has grown faster than revenue (7.1% vs -3.7% per year).
  • Operating income covered interest expense 2.8× in the latest year, down from 7.4× 5 years ago.
  • Total debt is 5.9× EBITDA.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 106.3% of earnings and 56.3% of free cash flow.
  • The dividend has declined 17.8% per year over the past 5 years.
Revenue & net income
-$438M $2B $5B $0 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
-11% 13% 37% 0% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Free cash flow (CFO − capex)
-$243M $171M $584M $0 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $1B $3B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$607M $30M $668M $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $3.4B $145M 30.6% 10.5% $274M $2.1B $33M
2024 $3.6B -$35M 23.9% 5.9% $584M $2.2B $72M
2023 $3.6B -$380M 18.5% -4.9% $438M $2.6B $32M
2022 $3.9B -$438M 22.2% -11.1% -$243M $3.0B $87M
2021 $4.9B $513M 29.8% 14.7% $165M $2.3B $244M
2020 $4.1B $387M 32.6% 14.2% $495M $1.5B $17M
2019 $3.2B $461M 32.3% 13.0% $184M $1.6B $19M
2018 $2.7B $64M 32.5% 7.5% $274M $2.0B $34M
2017 $2.6B $218M 36.8% 16.4% $294M $1.4B $121M
2016 $2.5B $315M 35.9% 17.9% $186M $1.2B $29M
2015 $160M $185M $1.2B $51M
2014 $167M $153M $784M $65M
2013 $161M $282M $571M $130M
2012 $107M $84M $783M $132M
2011 $168M $49M $795M $131M

Valuation over time

How the market has priced SMG against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 14.1 28.1 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/E
Price / sales (P/S)
0.0 0.7 1.4 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S
Dividend yield (%)
0.0 2.9 5.8 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
Dividend yield %

Frequently asked questions

Is SMG growing its revenue and profit?

Over the past 5 years, Scotts Miracle-Gro Co's revenue has declined 3.7% per year, and net income declined 17.8% per year. These are computed facts, not advice.

How much debt does SMG have?

As of FY2025, Scotts Miracle-Gro Co reported $2.1B of total debt against $33M of cash; operating income covered interest expense 2.8×.

What is SMG's profit margin?

In FY2025, gross margin was 30.6%, operating margin 10.5%, and net margin 4.3%.

What is SMG's P/E ratio?

As of Jun '26, Scotts Miracle-Gro Co traded at a price-to-earnings ratio of about 27.8× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.